LPL Financial
BBNX

LPL Financial’s Beta Bionics BBNX Stock Holding History

LPL Financial’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
17,278
-3,540
-17% -$42.1K ﹤0.01% 5533
2026
Q1 		$209K Buy
20,818
+10,120
+95% +$150K ﹤0.01% 5467
2025
Q4 		$326K Sell
10,698
-10,332
-49% -$276K ﹤0.01% 5085
2025
Q3 		$418K Buy
21,030
+4,545
+28% +$79.9K ﹤0.01% 4775
2025
Q2 		$240K Buy
16,485
+4,668
+40% +$66.1K ﹤0.01% 4954
2025
Q1 		$145K Buy
+11,817
New +$220K ﹤0.01% 4953

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

LPL Financial's BBNX Position: Q2 2026 in Review

LPL Financial reduced its Beta Bionics (BBNX) stake by 17% in Q2 2026, selling an estimated $42.1K and leaving 17,278 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #5533.

LPL Financial first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $418K in Q3 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • LPL Financial held 17,278 shares of Beta Bionics worth $271K as of Q2 2026.
  • LPL Financial sold 3,540 Beta Bionics shares in Q2 2026, an estimated $42.1K.
  • Beta Bionics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5533 holding.
  • LPL Financial first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • LPL Financial's Beta Bionics position peaked at $418K in Q3 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.